| # | Drug | Count |
|---|---|---|
| 0 | RIBAVIRIN | 12 |
| 1 | ATEZOLIZUMAB | 8 |
| 2 | BEVACIZUMAB | 8 |
| 3 | GLECAPREVIR AND PIBRENTASVIR | 6 |
| 4 | SORAFENIB | 6 |
| 5 | FUROSEMIDE | 5 |
| 6 | SPIRONOLACTONE | 5 |
| 7 | VELPATASVIR AND SOFOSBUVIR | 5 |
| 8 | OMEPRAZOLE | 4 |
| 9 | OMEPRAZOLE MAGNESIUM | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SOFOSBUVIR, VELPATASVIR, AND VOXILAPREVIR | 2 | 0.0018 |
| 1 | CASPOFUNGIN ACETATE | 1 | 0.0006 |
| 2 | GLECAPREVIR AND PIBRENTASVIR | 6 | 0.0005 |
| 3 | ETRAVIRINE | 2 | 0.0005 |
| 4 | VELPATASVIR AND SOFOSBUVIR | 5 | 0.0004 |
| 5 | RALTEGRAVIR | 2 | 0.0004 |
| 6 | SORAFENIB | 6 | 0.0003 |
| 7 | REGORAFENIB | 3 | 0.0003 |
| 8 | ABROCITINIB | 1 | 0.0003 |
| 9 | ATEZOLIZUMAB | 8 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] | 6 | 0.0004 |
| 1 | Hepatitis C Virus NS5A Inhibitor [EPC] | 11 | 0.0002 |
| 2 | Bismuth [EPC] | 1 | 0.0002 |
| 3 | Bile Acid [EPC] | 4 | 0.0002 |
| 4 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 8 | 0.0002 |
| 5 | Nucleoside Analog Antiviral [EPC] | 12 | 0.0001 |
| 6 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0001 |
| 7 | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] | 1 | 0.0001 |
| 8 | Pyridone [EPC] | 2 | 0.0000 |
| 9 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 8 | 0.0000 |